Barras M - Search Results

1

Development and validation of the Adverse Inpatient Medication Event model (AIME).

Falconer N, Barras M, Abdel-Hafez A, Radburn S, Cottrell N. Falconer N, et al. Among authors: barras m. Br J Clin Pharmacol. 2021 Mar;87(3):1512-1524. doi: 10.1111/bcp.14560. Epub 2020 Nov 5. Br J Clin Pharmacol. 2021. PMID: 32986855 Free article.

2

Modelling the occurrence and severity of enoxaparin-induced bleeding and bruising events.

Barras MA, Duffull SB, Atherton JJ, Green B. Barras MA, et al. Br J Clin Pharmacol. 2009 Nov;68(5):700-11. doi: 10.1111/j.1365-2125.2009.03518.x. Br J Clin Pharmacol. 2009. PMID: 19916994 Free PMC article. Clinical Trial.

3

Current dosing of low-molecular-weight heparins does not reflect licensed product labels: an international survey.

Barras MA, Kirkpatrick CM, Green B. Barras MA, et al. Br J Clin Pharmacol. 2010 May;69(5):520-8. doi: 10.1111/j.1365-2125.2010.03626.x. Br J Clin Pharmacol. 2010. PMID: 20573088 Free PMC article.

4

Systematic review of predictive risk models for adverse drug events in hospitalized patients.

Falconer N, Barras M, Cottrell N. Falconer N, et al. Among authors: barras m. Br J Clin Pharmacol. 2018 May;84(5):846-864. doi: 10.1111/bcp.13514. Epub 2018 Feb 22. Br J Clin Pharmacol. 2018. PMID: 29337387 Free PMC article.

5

Reply to Iuga and Genaidy 'Comment on Falconer et al. (2018) - the need for specific adverse drug reaction outcomes'.

Falconer N, Barras M, Cottrell N. Falconer N, et al. Among authors: barras m. Br J Clin Pharmacol. 2018 Aug;84(8):1857. doi: 10.1111/bcp.13633. Epub 2018 Jun 5. Br J Clin Pharmacol. 2018. PMID: 29873096 Free PMC article. No abstract available.

6

Defining and classifying terminology for medication harm: a call for consensus.

Falconer N, Barras M, Martin J, Cottrell N. Falconer N, et al. Among authors: barras m. Eur J Clin Pharmacol. 2019 Feb;75(2):137-145. doi: 10.1007/s00228-018-2567-5. Epub 2018 Oct 11. Eur J Clin Pharmacol. 2019. PMID: 30310967 Review.

7

How hospital pharmacists prioritise patients at high-risk for medication harm.

Falconer N, Barras M, Cottrell N. Falconer N, et al. Among authors: barras m. Res Social Adm Pharm. 2019 Oct;15(10):1266-1273. doi: 10.1016/j.sapharm.2018.11.003. Epub 2018 Nov 8. Res Social Adm Pharm. 2019. PMID: 30466812

8

Systematic review of interventions to improve safety and quality of anticoagulant prescribing for therapeutic indications for hospital inpatients.

Frazer A, Rowland J, Mudge A, Barras M, Martin J, Donovan P. Frazer A, et al. Among authors: barras m. Eur J Clin Pharmacol. 2019 Dec;75(12):1645-1657. doi: 10.1007/s00228-019-02752-8. Epub 2019 Sep 11. Eur J Clin Pharmacol. 2019. PMID: 31511939

9

A Narrative Review of Aspirin Resistance in VTE Prophylaxis for Orthopaedic Surgery.

van Oosterom N, Barras M, Bird R, Nusem I, Cottrell N. van Oosterom N, et al. Among authors: barras m. Drugs. 2020 Dec;80(18):1889-1899. doi: 10.1007/s40265-020-01413-w. Drugs. 2020. PMID: 33037568 Review.

10

A randomised trial of pharmacist-led discharge prescribing in an Australian geriatric evaluation and management service.

Finn S, D'arcy E, Donovan P, Kanagarajah S, Barras M. Finn S, et al. Among authors: barras m. Int J Clin Pharm. 2021 Aug;43(4):847-857. doi: 10.1007/s11096-020-01184-0. Epub 2020 Nov 2. Int J Clin Pharm. 2021. PMID: 33136253 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters